PLUR
Pluri, Inc.
NASDAQ · Healthcare · Biotechnology · IL
$1.08
+0.00%Income statement
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.0M | 1.0M | 1.3M | 326.0K | 287.0K |
| Cost of Revenue | 563.0K | 563.0K | 682.0K | 4.0K | 9.0K |
| Gross Profit | 453.0K | 453.0K | 654.0K | 322.0K | 278.0K |
| Operating Expenses | |||||
| R&D Expense | 15.1M | 15.3M | 12.9M | 12.4M | 15.7M |
| SG&A Expense | 9.9M | 10.3M | 10.0M | 10.0M | 11.8M |
| General & Admin Expense | 10.3M | 10.3M | 10.0M | 10.0M | 11.8M |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | — | (214.0K) | — | — | — |
| Total Operating Expenses | 25.0M | 25.4M | 22.8M | 22.5M | 27.5M |
| Cost and Expenses | 26.0M | 26.0M | 23.5M | 22.5M | 27.5M |
| Operating Income (EBIT) | (25.0M) | (24.9M) | (22.2M) | (22.2M) | (27.2M) |
| Non-Operating | |||||
| Interest Income | 488.0K | 488.0K | 1.1M | 1.3M | 1.1M |
| Interest Expense | 932.0K | (932.0K) | 873.0K | 866.0K | 843.0K |
| Net Interest Income | (444.0K) | (444.0K) | 271.0K | 448.0K | 241.0K |
| Other Non-Op Income/Expense | (434.0K) | (456.0K) | (1.1M) | 814.0K | (1.6M) |
| Non-Operating Income (excl Interest) | (476.0K) | — | 206.0K | (1.7M) | 798.0K |
| EBT (Pre-Tax Income) | (25.4M) | (25.4M) | (23.3M) | (21.3M) | (28.9M) |
| Income Tax Expense | (17.0K) | (25.0K) | (5.0K) | — | — |
| Bottom Line | |||||
| Net Income | (24.4M) | (23.8M) | (22.6M) | (20.9M) | (28.3M) |
| Earnings from Cont. Ops | (25.4M) | (25.4M) | (23.3M) | (21.3M) | (28.9M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (24.4M) | (23.8M) | (22.6M) | (20.9M) | (28.3M) |
| Per Share | |||||
| Basic EPS | ($2.45) | ($2.44) | ($3.56) | ($3.99) | ($6.18) |
| Diluted EPS | ($2.45) | ($2.44) | ($3.56) | ($3.99) | ($6.18) |
| Revenue Per Share | $0.09 | $0.10 | $0.21 | $0.06 | $0.06 |
| Shares | |||||
| Basic Shares Outstanding | 10.8M | 9.7M | 6.3M | 5.2M | 4.6M |
| Diluted Shares Outstanding | 10.8M | 9.7M | 6.3M | 5.2M | 4.6M |
| Profitability Metrics | |||||
| EBITDA | (24.0M) | (24.4M) | (22.1M) | (20.2M) | (27.7M) |
| D&A | 511.0K | 511.0K | 316.0K | 253.0K | 362.0K |
| EBIT | (24.5M) | (24.9M) | (22.4M) | (20.5M) | (28.0M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026